CLDI · Calidi Biotherapeutics, Inc. · Documents
$0.72
-0.05 (-5.90%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.98M
Shares
2.58M
Volume · Oct 21
63.67K
Avg daily vol (58 sessions)
150.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-12-15 | — | |
| 8-K | — | 2022-11-14 | 2022-11-11 | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-09-16 | 2022-09-13 | |
| 8-K | — | 2022-09-09 | — | |
| DEF 14A | — | 2022-08-23 | 2022-09-09 | |
| 10-Q | — | 2022-08-10 | 2022-06-30 | |
| PRE 14A | — | 2022-08-08 | — | |
| 10-Q | — | 2022-05-11 | 2022-03-31 | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 10-Q | — | 2021-11-12 | 2021-09-30 | |
| 8-K | — | 2021-10-28 | — | |
| 8-K | — | 2021-09-20 | 2021-09-14 | |
| 8-K | — | 2021-09-15 | 2021-09-09 | |
| S-1/A | — | 2021-09-07 | — | |
| S-1 | — | 2021-08-24 | — |
Showing 151–166 of 166 filings